3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
5
Classical hematology
3
Thoracic
1
Myeloid
1
Breast
1
Conditions
Myelodysplastic Syndromes
171
Leukemia, Myeloid, Acute
152
Myeloproliferative Disorders
71
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
71
Precursor Cell Lymphoblastic Leukemia-Lymphoma
54
Primary Myelofibrosis
50
Leukemia, Myelomonocytic, Chronic
44
Lymphoma, Non-Hodgkin
37
Leukemia
26
Polycythemia Vera
25
Hodgkin Disease
23
Thrombocythemia, Essential
21
Multiple Myeloma
21
Myelodysplastic-Myeloproliferative Diseases
20
Leukemia, Lymphocytic, Chronic, B-Cell
20
Leukemia, Biphenotypic, Acute
19
Hematologic Neoplasms
17
Neoplasms
16
Anemia, Refractory, with Excess of Blasts
15
Leukemia, Myeloid, Chronic-Phase
14
Sarcoma
13
Histiocytosis, Langerhans-Cell
13
Glioma
13
Recurrence
12
Neuroblastoma
12
Wilms Tumor
11
Rhabdoid Tumor
11
Osteosarcoma
11
Neuroectodermal Tumors, Primitive, Peripheral
11
Medulloblastoma
11
Interventions
Levofloxacin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neutropenia
×
Myeloid
×
90 days
×
Clear all
NCT07528417
2026-04-22
MYELO-CAN:ABX
University of Manitoba
Phase 2
Not yet recruiting
75 enrolled